BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 33250629)

  • 1. Cannabis in Gastroenterology: Watch Your Head! A Review of Use in Inflammatory Bowel Disease, Functional Gut Disorders, and Gut-Related Adverse Effects.
    Nasser Y; Woo M; Andrews CN
    Curr Treat Options Gastroenterol; 2020; 18(4):519-530. PubMed ID: 33250629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids and the Gastrointestinal Tract.
    Camilleri M; Zheng T
    Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3217-3229. PubMed ID: 37678488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review].
    Volz MS; Siegmund B; Häuser W
    Schmerz; 2016 Feb; 30(1):37-46. PubMed ID: 26809974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis and Turmeric as Complementary Treatments for IBD and Other Digestive Diseases.
    Quezada SM; Cross RK
    Curr Gastroenterol Rep; 2019 Jan; 21(2):2. PubMed ID: 30635796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cannabis in inflammatory bowel diseases.
    Perisetti A; Rimu AH; Khan SA; Bansal P; Goyal H
    Ann Gastroenterol; 2020; 33(2):134-144. PubMed ID: 32127734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Cannabinoids in the Treatment of Inflammatory Bowel Disease (IBD): A Review of the Literature.
    Nduma BN; Mofor KA; Tatang J; Ekhator C; Ambe S; Fonkem E
    Cureus; 2023 Mar; 15(3):e36148. PubMed ID: 37065370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cannabis in digestive disorders.
    Goyal H; Singla U; Gupta U; May E
    Eur J Gastroenterol Hepatol; 2017 Feb; 29(2):135-143. PubMed ID: 27792038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis and Cannabis Derivatives for Abdominal Pain Management in Inflammatory Bowel Disease.
    Bogale K; Raup-Konsavage W; Dalessio S; Vrana K; Coates MD
    Med Cannabis Cannabinoids; 2021; 4(2):97-106. PubMed ID: 35224429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
    Hasenoehrl C; Storr M; Schicho R
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):329-337. PubMed ID: 28276820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis for inflammatory bowel disease.
    Naftali T; Mechulam R; Lev LB; Konikoff FM
    Dig Dis; 2014; 32(4):468-74. PubMed ID: 24969296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids and gastrointestinal motility: Pharmacology, clinical effects, and potential therapeutics in humans.
    Camilleri M
    Neurogastroenterol Motil; 2018 Sep; 30(9):e13370. PubMed ID: 29745439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Use of Cannabis in Inflammatory Bowel Disease.
    Ahmed W; Katz S
    Gastroenterol Hepatol (N Y); 2016 Nov; 12(11):668-679. PubMed ID: 28035196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis and the Gastrointestinal Tract.
    Cohen L; Neuman MG
    J Pharm Pharm Sci; 2020; 23():301-313. PubMed ID: 32762830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid pharmacology and therapy in gut disorders.
    Uranga JA; Vera G; Abalo R
    Biochem Pharmacol; 2018 Nov; 157():134-147. PubMed ID: 30076849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease.
    Gotfried J; Naftali T; Schey R
    Gastroenterology; 2020 Jul; 159(1):62-80. PubMed ID: 32333910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis use amongst patients with inflammatory bowel disease.
    Lal S; Prasad N; Ryan M; Tangri S; Silverberg MS; Gordon A; Steinhart H
    Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):891-6. PubMed ID: 21795981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids and gastrointestinal motility: animal and human studies.
    Aviello G; Romano B; Izzo AA
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():81-93. PubMed ID: 18924447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease?
    Ambrose T; Simmons A
    J Crohns Colitis; 2019 Mar; 13(4):525-535. PubMed ID: 30418525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis hyperemesis syndrome: an update on the pathophysiology and management.
    Perisetti A; Gajendran M; Dasari CS; Bansal P; Aziz M; Inamdar S; Tharian B; Goyal H
    Ann Gastroenterol; 2020; 33(6):571-578. PubMed ID: 33162734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.